Skip to main content

Diagnostics & research Stocks - Companies, Performance & Financial Metrics

Browse 46 diagnostics & research stocks with financial metrics and performance data (Healthcare sector).

Diagnostics & research Stocks

46 stocks in the diagnostics & research industry. Click column headers to sort.

#
1
TMO logo
TMO
Thermo Fisher Scientific Inc.$613.78$227.71B$46.34B$6.98B$18.621.77M
2
DHR logo
DHR
Danaher Corporation$207.66$146.94B$25.11B$4.00B$5.633.81M
3
NTRA logo
NTRA
Natera, Inc.$328.18$46.44B$2.50B-$226.31M$-1.641.34M
4
IQV logo
IQV
IQVIA Holdings Inc.$267.77$44.80B$16.98B$1.38B$8.081.46M
5
IDXX logo
IDXX
IDEXX Laboratories, Inc.$535.38$43.19B$4.45B$1.10B$13.56583.72K
6
A logo
A
Agilent Technologies, Inc.$150.86$42.84B$7.23B$1.41B$4.972.02M
7
WAT logo
WAT
Waters Corporation$409.38$33.63B$4.27B$230.14M$3.25760.26K
8
ILMN logo
ILMN
Illumina, Inc.$218.22$33.39B$4.49B$825.00M$5.372.00M
9
MTD logo
MTD
Mettler-Toledo International Inc.$1,345.26$27.13B$4.13B$905.61M$44.46172.66K
10
LH logo
LH
Labcorp Holdings Inc.$326.89$26.80B$14.35B$1.00B$12.08665.58K
11
DGX logo
DGX
Quest Diagnostics Incorporated$237.14$26.56B$11.56B$1.06B$9.46861.57K
12
GH logo
GH
Guardant Health, Inc.$161.41$21.45B$1.18B-$453.44M$-3.502.12M
13
MEDP logo
MEDP
Medpace Holdings, Inc.$591.29$16.88B$2.78B$491.50M$16.92243.88K
14
RVTY logo
RVTY
Revvity, Inc.$130.22$14.57B$2.89B$226.45M$1.991.62M
15
CRL logo
CRL
Charles River Laboratories International, Inc.$288.50$14.12B$4.03B-$184.65M$-3.75915.21K
16
ICLR logo
ICLR
ICON Public Limited Company$164.85$12.75B$8.29B$42.34M$0.54716.49K
17
QGEN logo
QGEN
Qiagen N.V.$43.47$9.08B$2.10B$402.17M$1.932.81M
18
TWST logo
TWST
Twist Bioscience Corporation$124.72$7.70B$409.48M-$81.28M$-1.331.68M
19
RDNT logo
RDNT
RadNet, Inc.$73.71$5.68B$2.14B-$14.19M$-0.19724.91K
20
SHC logo
SHC
Sotera Health Company$18.90$5.44B$1.19B$117.80M$0.412.68M
21
BLLN logo
BLLN
BillionToOne, Inc.$99.39$5.27B$354.54M$30.52M$0.83757.73K
22
ADPT logo
ADPT
Adaptive Biotechnologies Corporation$24.28$3.88B$308.08M-$63.85M$-0.402.21M
23
VCYT logo
VCYT
Veracyte, Inc.$42.53$3.49B$561.90M$114.48M$1.411.39M
24
GRAL logo
GRAL
GRAIL, Inc.$80.34$3.27B$156.12M-$395.32M$-10.32690.56K
25
CDNA logo
CDNA
CareDx, Inc.$50.88$2.72B$458.09M-$114.92M$-2.171.19M
26
WGS logo
WGS
GeneDx Holdings Corp.$85.99$2.52B$442.68M-$77.81M$-2.63702.81K
27
NEO logo
NEO
NeoGenomics, Inc.$17.38$2.27B$766.29M-$51.88M$-0.502.20M
28
PSNL logo
PSNL
Personalis, Inc.$17.20$1.79B$64.52M-$95.55M$-1.023.44M
29
OPK logo
OPK
OPKO Health, Inc.$1.64$1.24B$587.89M-$72.89M$-0.104.31M
30
CSTL logo
CSTL
Castle Biosciences, Inc.$32.91$1.00B$357.28M-$19.41M$-0.65456.85K
31
FLGT logo
FLGT
Fulgent Genetics, Inc.$19.73$552.54M$323.93M-$84.38M$-2.80296.73K
32
PRE logo
PRE
Prenetics Global Limited$25.44$432.04M$113.75M-$71.04M$-4.72224.26K
33
MYGN logo
MYGN
Myriad Genetics, Inc.$3.19$302.41M$806.60M-$112.60M$-1.202.37M
34
BDSX logo
BDSX
Biodesix, Inc.$26.18$252.79M$96.10M-$31.96M$-3.93114.21K
35
XGN logo
XGN
Exagen Inc.$7.58$180.82M$68.38M-$20.17M$-0.90393.34K
36
IMDX logo
IMDX
Insight Molecular Diagnostics Inc.$4.13$142.56M$1.95M-$47.84M$-1.46184.77K
37
BNR logo
BNR
Burning Rock Biotech Limited$11.99$105.36M$76.66M-$8.84M$-0.8713.41K
38
BIAF logo
BIAF
bioAffinity Technologies, Inc.$15.27$68.63M$5.61M-$15.88M$-5.864.64M
39
PRPO logo
PRPO
Precipio, Inc.$27.40$48.86M$25.42M-$922.00K$-0.56143.71K
40
MBAI logo
MBAI
Check-Cap Ltd.$6.50$40.51M$0.00-$25.15M$-4.3023.35K
41
MDXH logo
MDXH
MDxHealth SA$0.75$39.04M$136.09M-$43.02M$-0.8611.85M
42
QUCY logo
QUCY
Quantum Cyber N.V.$1.59$18.76M$1.18M-$24.05M$-4.45861.09K
43
ADVB logo
ADVB
Advanced Biomed Inc.$9.34$11.99M$0.00$5.28M$4.66240.56K
44
XWEL logo
XWEL
XWELL, Inc.$0.98$7.22M$28.83M-$26.49M$-4.3934.88K
45
NDRA logo
NDRA
ENDRA Life Sciences Inc.$6.05$4.76M$0.00-$9.25M$-9.5932.55K
46
ISPC logo
ISPC
iSpecimen Inc.$1.54$5.26K$1.03M-$11.10M$-135.88382.52K

About the Diagnostics & research Industry

The Diagnostics & research industry comprises 46 publicly traded companies within the Healthcare sector that share similar business models and competitive dynamics.

Company Types

  • - Industry leaders with market share and scale
  • - Growth companies expanding rapidly
  • - Value opportunities below peer averages
  • - Dividend payers for income investors

Key Considerations

  • - Compare valuation ratios to industry peers
  • - Assess competitive positioning and moats
  • - Monitor regulatory and technology trends
  • - Evaluate financial health and cash flow